Expanded Portfolio of SARS-CoV-2 Variant Reference Material

CLINICAL DIAGNOSTIC QUALITY SOLUTIONS FOR SARS-COV-2 VARIANT ANALYSIS

In response to the continued public health emergency surrounding the global spread of COVID-19, we have initiated development to expand our portfolio of SARS-CoV-2 Variant Reference Materials to include the Omicron B.1.1.529 variant. Our variant quality solutions are ideal tools for the following applications:

  • Performance confirmation of existing SARS-CoV-2 molecular assays with different variants
  • Reference materials for SARS-CoV-2 variant genotyping assays
  • Reference materials for SARS-CoV-2 NGS assays

For information on the complete portfolio of SARS-CoV-2 Quality Solutions currently available from LGC SeraCare, please visit www.seracare.com/SARS-CoV-2

Please complete the form at the right if you would like more information about the Omicron reference material in development or to be notified when it is released.

Please provide your contact information if you would like us to reach out to you with more information